CYP2C8 *3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride

Cinitapride is a gastrointestinal prokinetic drug, prescribed for the treatment of functional dyspepsia, and as an adjuvant therapy for gastroesophageal reflux disease. In this study, we aimed to explore the impact of relevant variants in CYP3A4 and CYP2C8 and other pharmacogenes, along with demogra...

Descripción completa

Detalles Bibliográficos
Autores principales: Campodónico, Diana María, Zubiaur, Pablo, Soria‐Chacartegui, Paula, Casajús, Ana, Villapalos‐García, Gonzalo, Navares‐Gómez, Marcos, Gómez‐Fernández, Antía, Parra‐Garcés, Raúl, Mejía‐Abril, Gina, Román, Manuel, Martín‐Vílchez, Samuel, Ochoa, Dolores, Abad‐Santos, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652446/
https://www.ncbi.nlm.nih.gov/pubmed/36065758
http://dx.doi.org/10.1111/cts.13386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652446/
https://www.ncbi.nlm.nih.gov/pubmed/36065758
http://dx.doi.org/10.1111/cts.13386

Ejemplares similares